The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 1,730 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 6,967 | 98,000 | SH | SOLE | 98,000 | 0 | 0 | ||
| CARDINAL HEALTH INC | COM | 14149Y108 | 4,668 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| CIGNA CORP NEW | COM | 125523100 | 4,717 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 6,477 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| KEMPHARM INC | COM NEW | 488445206 | 4,680 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 4,418 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 2,258 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| UTAH MED PRODS INC | COM | 917488108 | 7,337 | 86,000 | SH | SOLE | 86,000 | 0 | 0 | ||
| VIATRIS INC | COM | 92556V106 | 4,090 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | ||